The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Clareeze Allergy 10 mg Tablets

Phoenix LabsPA1113/015/001

Main Information

Trade NameClareeze Allergy 10 mg Tablets
Active SubstancesLoratadine
Dosage FormTablet
Licence HolderPhoenix Labs
Licence NumberPA1113/015/001

Group Information

ATC CodeR06AX Other antihistamines for systemic use
R06AX13 loratadine


License statusAuthorised
Licence Issued24/08/2001
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceProduct not subject to prescription for pack sizes of up to 30 tablets. Supply as an over the counter item through pharmacies only.
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back